Company / Depreciation & Amortization
HARROW, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.9M
FY2025
5-year range
$1.5M / $1.9M
FY2021-FY2025
Trend
+3.5%
vs FY2024
Sector context
#102 of 163
Health Care
What the data says
At $2M, HARROW, INC.'s depreciation & amortization ranks #62 of 163 in the Health Care sector. Depreciation & Amortization has increased for 3 consecutive years, from $1M in FY2022 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +0.4%.
Increased from $2M to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
#62 of 163 in Health CareTop 37% of 163This company $1.9M Sector average $219.4M
▼
-99.1% below sector average
Key checks
Key Insights
- HARROW, INC.'s depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 3.5% year-over-year.
- Ranks #102 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9M | +3.5% |
| FY2024 | $1.9M | +20.9% |
| FY2023 | $1.5M | +3.6% |
| FY2022 | $1.5M | -14.0% |
| FY2021 | $1.7M | -8.7% |
| FY2020 | $1.9M | +16.9% |
| FY2019 | $1.6M | +0.0% |
| FY2018 | $1.6M | +14.8% |
| FY2017 | $1.4M | +449.4% |
| FY2016 | $255.0K | +589.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026